Aetna Modified CPB 0016 for Back Pain Invasive Procedures — What Billing Teams Need to Know in 2026
TL;DR: Aetna, a CVS Health company, modified CPB 0016 governing invasive procedures for back pain, effective February 12, 2026. Here's what changes for billing teams.
Aetna's back pain invasive procedures coverage policy under CPB 0016 has been updated as of February 12, 2026. This is one of the most financially significant clinical policy updates Aetna issues — back pain procedures represent a high volume of claims across orthopedic, pain management, neurosurgery, and physical medicine practices. The policy does not list specific CPT or HCPCS codes in the data available at publication time, but the scope of CPB 0016 is broad. If your practice bills for spinal injections, nerve blocks, radiofrequency ablation, spinal cord stimulation, or related interventional pain procedures, this update belongs on your radar before claims start moving through your system under the new criteria.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Back Pain — Invasive Procedures — CPB 0016 |
| Policy Code | CPB 0016 |
| Change Type | Modified |
| Effective Date | February 12, 2026 |
| Impact Level | High |
| Specialties Affected | Pain Management, Orthopedic Surgery, Neurosurgery, Physical Medicine & Rehabilitation, Anesthesiology, Interventional Radiology |
| Key Action | Audit your medical necessity documentation and prior authorization workflows against the updated CPB 0016 criteria before submitting claims dated on or after February 12, 2026. |
Aetna Back Pain Invasive Procedures Coverage Criteria and Medical Necessity Requirements 2026
CPB 0016 is Aetna's clinical policy bulletin for invasive procedures used to treat back pain. It covers a wide range of interventional treatments — from epidural steroid injections and facet joint injections to spinal cord stimulation and intradiscal procedures. This is not a narrow policy. The scope touches nearly every procedure a pain management or spine practice bills regularly.
Aetna's coverage policy for these procedures has always been grounded in medical necessity. The general framework requires that conservative treatment — physical therapy, medication management, and similar non-invasive approaches — has been tried and failed before invasive procedures are authorized. That threshold matters for prior authorization approvals and for defending claims on appeal after a denial.
The specific updated criteria introduced in the February 12, 2026 modification are not detailed in the policy data available at publication time. This is exactly the kind of situation where you need to pull the full CPB 0016 document directly from Aetna's clinical policy library and do a line-by-line comparison against the prior version. The effective date is already live. If your team hasn't reviewed what changed, you're billing under the new rules without knowing them.
Back pain invasive procedure billing is high-exposure territory. Aetna scrutinizes these claims heavily. Prior authorization requirements apply to most covered procedures under this policy, and the medical necessity documentation requirements are specific — not just "patient has back pain." You need documented diagnosis, failed conservative treatment history, functional limitations, and provider credentials aligned to Aetna's criteria.
One consistent pattern with CPB 0016 revisions: Aetna tends to tighten the number of allowed injections per year, add or remove specific procedure types from the covered list, or shift certain techniques from covered to experimental status. If your volume includes radiofrequency ablation, spinal cord stimulator trials, or intradiscal therapies, those are the areas most likely to have changed. Check those first.
If you're not sure how the February 12 changes apply to your payer mix and procedure volume, talk to your compliance officer before processing pending claims. A claim denial now is cheaper than a retroactive audit later.
Aetna CPB 0016 Exclusions and Non-Covered Indications
Aetna's back pain coverage policy has historically excluded or designated as experimental a meaningful set of invasive procedures. Based on the established scope of CPB 0016 — and consistent with prior versions of this policy — the following categories have typically been treated as non-covered or experimental. The February 12, 2026 modification may have added to or changed these designations. Treat this as a starting framework, not a final list.
Procedures that have carried experimental or investigational status under CPB 0016 in prior versions include intradiscal electrothermal therapy (IDET), percutaneous disc decompression techniques, platelet-rich plasma (PRP) injections for disc or joint pathology, and certain implantable drug delivery systems. Stem cell therapies applied to spinal conditions have also consistently fallen outside covered status.
The real issue here is that Aetna's definition of "experimental" shifts with each policy update. A procedure your team billed without issue last year may now require a different billing approach — or may no longer be covered at all. Run your CPT utilization report for the past 12 months against the updated CPB 0016 criteria. Anything that hits a changed designation needs a workflow update before the next claim goes out.
Coverage Indications at a Glance
The specific coverage indications introduced or modified in the February 12, 2026 update are not available in the policy data at publication time. The table below reflects the general CPB 0016 coverage framework based on established Aetna policy patterns for back pain invasive procedures. Verify each indication against the current CPB 0016 document before submitting claims.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Epidural steroid injections (cervical, thoracic, lumbar) | Covered when criteria met | Not specified in available data | Medical necessity documentation required; frequency limits apply |
| Facet joint injections / medial branch blocks | Covered when criteria met | Not specified in available data | Prior authorization typically required; number of injections per year limited |
| Radiofrequency ablation / neurotomy | Covered when criteria met | Not specified in available data | Requires positive diagnostic block response; criteria may have changed in Feb 2026 update |
| Spinal cord stimulator trial | Covered when criteria met | Not specified in available data | Psychological evaluation and failed conservative treatment required |
| Spinal cord stimulator implant (permanent) | Covered when criteria met | Not specified in available data | Successful trial period required; prior authorization required |
| Trigger point injections | Covered — limited | Not specified in available data | Frequency restrictions apply; documentation requirements are strict |
| Intradiscal procedures (IDET, nucleoplasty) | Experimental / Not Covered | Not specified in available data | Historically excluded; verify against February 2026 update |
| PRP injections for spinal conditions | Experimental / Not Covered | Not specified in available data | Consistently non-covered under prior CPB 0016 versions |
| Stem cell therapy for back pain | Experimental / Not Covered | Not specified in available data | Not covered; no expected change based on policy history |
Aetna Back Pain Invasive Procedures Billing Guidelines and Action Items 2026
The effective date is February 12, 2026. That date is already past. If your team hasn't acted yet, start today.
| # | Action Item |
|---|---|
| 1 | Pull the current CPB 0016 document from Aetna's clinical policy library now. Go directly to the source. The updated version reflects the February 12 changes. Read it against the prior version line by line. If you don't have access to the prior version, PayerPolicy's version diff tool shows exactly what changed between iterations. |
| 2 | Audit your prior authorization workflows for every procedure category under CPB 0016. Prior authorization requirements are the first place Aetna denies back pain claims. If the February update changed the criteria for any procedure type your practice bills regularly, your PA request documentation needs to match the new standard before your next submission. |
| 3 | Update your medical necessity documentation templates. Back pain invasive procedure billing lives and dies on documentation. Confirm your intake and pre-procedure documentation captures failed conservative treatment, functional status, diagnosis specificity, and any updated clinical criteria from the February 12 revision. Templates that worked last month may not satisfy the new requirements. |
| 4 | Run a CPT utilization report for back pain procedures billed in the past 90 days. Identify which codes generated the most claims volume. Cross-reference those against the updated CPB 0016 criteria. Any code tied to a changed coverage designation — especially anything that may have shifted to experimental status — needs immediate attention. |
| 5 | Flag any pending claims dated on or after February 12, 2026 for review. Claims in your queue that haven't been submitted yet should go through a quick compliance check against the new policy. Submitting under outdated criteria is the fastest way to generate a wave of claim denials that take months to resolve. |
| 6 | Check reimbursement rates for any procedures affected by changed coverage status. If a procedure moved from a covered to non-covered designation, your billing team needs to know before it hits the remittance. The same applies to procedures where frequency limits changed — Aetna will deny excess units, and those denials are harder to appeal than prior authorization issues. |
| 7 | Loop in your compliance officer if your practice does high volume in radiofrequency ablation, spinal cord stimulation, or intradiscal procedures. Those categories have historically seen the most change with CPB 0016 revisions. High-volume, high-dollar procedures in shifting coverage categories are exactly the scenario your compliance officer needs to know about. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Back Pain Invasive Procedures Under CPB 0016
The current policy data for the February 12, 2026 CPB 0016 modification does not include a specific list of CPT, HCPCS, or ICD-10 codes. This post will be updated when code-level data becomes available.
This does not mean codes are unaffected. CPB 0016 covers a wide range of back pain invasive procedure billing codes. The absence of a published code list in the available data means your team needs to work directly from the full CPB 0016 document to identify which codes fall under the updated criteria.
Pull the policy directly from Aetna's clinical policy library at app.payerpolicy.org/p/aetna/0016. Cross-reference the procedure categories in the updated CPB 0016 against your practice's CPT code mix. That comparison is your working code list until a formal code appendix is published.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.